Skip to main content

Stoke Therapeutics, Inc.

STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001623526

In the last 90 days, Stoke Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 197 institutions reported holding it in 13F filings for Q2 2026, worth $2.49B in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Stoke Therapeutics, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of STOK: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders9499+5
Shares35.4M41.4M+5.91M (+16.7%)
Value$849.6M$870.6M+$21.0M (+2.5%)

New holders (20)

Institutions that held Stoke Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to STOK in Q1 2022
InstitutionSharesValue% of portfolio
Healthcare of Ontario Pension Plan Trust Fund1,336,500$28.1M0.10%
Wellington Management Group LLP1,188,115$25.0M0.00%
Boothbay Fund Management, LLC205,463$4.33M0.14%
Norges Bank145,600$3.06M0.00%
Invesco Ltd.131,674$2.77M0.00%
Amitell Capital Pte Ltd64,807$1.36M0.99%
Teachers Retirement System of the State of Kentucky36,124$760.0K0.01%
Qube Research & Technologies Ltd25,030$527.0K0.00%
Virginia Retirement Systems Et Al15,300$322.0K0.00%
Jump Financial, LLC14,850$312.0K0.01%
Renaissance Technologies LLC12,100$255.0K0.00%
Engineers Gate Manager LP9,958$210.0K0.01%
Amalgamated Bank3,118$66.0K0.00%
Amalgamated Financial Corp.3,118$66.0K0.00%
Point72 Hong Kong Ltd1,290$27.0K0.00%
Ensign Peak Advisors, Inc1,190$25.0K0.00%
Signaturefd, LLC562$12.0K0.00%
Quadrant Capital Group LLC113$2.00K0.00%
Lindbrook Capital, LLC101$2.00K0.00%
Captrust Financial Advisors68$1.00K0.00%

Sold out (15)

Institutions that held Stoke Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.